European Journal of Heart Failure

DECEMBER 7, 2023

Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heart failure (HF) with preserved ejection fraction (HFpEF). Overall, 60.9% of patients had BMI ≥30 kg/m 2.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Obesity Heart Failure BMI 40

Circulation

SEPTEMBER 2, 2024

Circulation, Volume 150, Issue 10 , Page e224-e225, September 3, 2024.

Preserved Ejection Fraction 45

Preserved Ejection Fraction Quality of Life Article Heart Failure 45

The American Journal of Cardiology

APRIL 15, 2024

Publication date: Available online 13 April 2024 Source: The American Journal of Cardiology Author(s): Syed Imran Ahmed, Jonathan Kenyon, Hayley E. Billingsley, Hannah Salmons, Natalie J. Bohmke, Roshanak Markley, Antonio Abbate, Danielle L. Kirkman, Youngdeok Kim, Salvatore Carbone

Preserved Ejection Fraction 40

Preserved Ejection Fraction Quality of Life Heart Failure 40

DAIC

APRIL 22, 2024

RELIEVE-HF failed to meet its primary efficacy endpoint and did not reduce heart failure events or improve quality of life in heart failure patients with a preserved ejection fraction (HFpEF). For more information: www.corviamedical.com If you enjoy this content, please share it with a colleague

Preserved Ejection Fraction 105

Preserved Ejection Fraction Quality of Life Heart Failure Pacemaker 105

European Journal of Heart Failure

NOVEMBER 29, 2023

Methods Between 1 November 2018 and 31 December 2020, 10 162 patients with chronic or acute/worsening HF with reduced, mildly reduced, or preserved ejection fraction were enrolled from 220 centres in 41 European or ESC affiliated countries.

Heart Failure 75

Heart Failure Preserved Ejection Fraction Quality of Life Biomarkers 75

European Journal of Heart Failure

DECEMBER 20, 2023

Abstract Introduction Emerging evidence suggests a beneficial effect of higher heart rates in some patients with heart failure with preserved ejection fraction (HFpEF).

Quality of Life 40

Quality of Life Preserved Ejection Fraction Pacemaker Heart Failure 40

Heart BMJ

FEBRUARY 12, 2024

To be familiar with the specific considerations of exercise training prescription in specific HF population groups including HF with preserved ejection fraction. To understand the key principles of exercise training prescription in people with HF. cross-ref type="bib".

Exercise 40

Exercise Heart Failure Preserved Ejection Fraction Pharmacology 40

The British Journal of Cardiology

AUGUST 21, 2024

In the only large, randomised trial of patients with HF with reduced ejection fraction (HFrEF), digoxin demonstrated a reduction in hospitalisation with no adverse effect on total mortality but patients in AF were excluded.

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Preserved Ejection Fraction Quality of Life 52

DAIC

APRIL 9, 2024

Maron, MD “Our findings provide enthusiasm that a novel drug therapy with ninerafaxstat may provide nonobstructive HCM patients an opportunity to achieve a better quality of life by decreasing symptom burden and improving exercise capacity,” said Martin S. The study was funded by Imbria Pharmaceuticals, developer of ninerafaxstat.

Cardiomyopathy 52

Cardiomyopathy Quality of Life Preserved Ejection Fraction Chest Pain 52

HeartRhythm

APRIL 30, 2024

Introduction: The PACE HFpEF trial is a prospective, single-center, randomized multiple crossover study investigating the effects of pacing modality and accelerated pacing on quality of life, NT-proBNP, and functional capacity in patients with heart failure with preserved ejection fraction (HFpEF) without pacing indication.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Quality of Life Physiology 40

CardiacWire

AUGUST 2, 2024

Lilly’s blockbuster GLP-1 tirzepatide appears poised to become the next major HFpEF drug, after topline results from the SUMMIT trial showed that it significantly improved both outcomes and symptoms among patients with heart failure with preserved ejection fraction and obesity.

Outcomes 59

Outcomes Preserved Ejection Fraction Heart Failure Obesity 59

DAIC

MARCH 29, 2024

The primary effectiveness endpoint was a composite of death, heart transplant/left ventricular assist device (LVAD) implantation, HF hospitalization, outpatient HF worsening, and quality of life. HFpEF is HF with preserved ejection fraction in which pressure builds up in the heart and lungs due to a stiffened left ventricle.

Preserved Ejection Fraction 111

Preserved Ejection Fraction Heart Failure Quality of Life Hospital 111

DAIC

APRIL 6, 2024

The trial, called RELIEVE-HF , is the first randomized placebo-procedure controlled trial of interatrial shunting that included patients with both major types of heart failure : heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

DAIC

APRIL 6, 2024

The trial, called RELIEVE-HF , is the first randomized placebo-procedure controlled trial of interatrial shunting that included patients with both major types of heart failure : heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

Heart Failure 98

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 98